U.S. health agencies are investing in vaccines that are aimed at preventing cancer from returning, officials said March 22.
The Department of Health and Human Services (HHS) and the National Cancer Institute have launched a public-private partnership to pay for clinical trials that will test vaccines developed to generate an immune attack on tumors, the agencies said.
“Beating cancer once shouldn’t mean living in fear of its return,” HHS stated in a post on Facebook. The agencies are “spearheading a $200M public-private partnership to drive innovative cancer treatments that prevent recurrence,” it stated.
Dr. Anthony Letai, director of the National Cancer Institute, wrote on X that cancer vaccines “show real promise, especially for hard-to-treat cancer.”…